Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy-Reference-Cited by-同舟云学术

Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy

Published:2023-09-22 Issue:1 Volume:78 Page:122-124
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Brock James B¹^ORCID,Herrington Peyton¹,Hickman Melissa¹,Hickman Aubri¹

Affiliation:

1. Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center . Jackson, Mississippi , USA

Abstract

Abstract We report 12 patients with persistent viremia on oral antiretroviral therapy who were initiated on injectable cabotegravir/rilpivirine (iCAB/RPV) without oral lead-in. All patients achieved viral suppression without any virologic rebound. iCAB/RPV may be considered as an option for patients unable to maintain suppression on oral antiretroviral therapy.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad511/51686255/ciad511.pdf

Reference6 articles.

1. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2 M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study;Overton;Lancet,2021

2. Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study;Orkin;Lancet HIV,2021

3. Cabotegravir-rilpivirine treatment initiation in a nonvirologically suppressed patient;Barnett;AIDS,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fully injectable antiretroviral multitherapy to overcome decades of virological failure in three women with hiv-1 and non-adherent to oral drugs;International Journal of Antimicrobial Agents;2024-09

2. Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system;Implementation Science Communications;2024-08-29

3. Strategic use of salvage long-acting antiretrovirals in the setting of resistance;American Journal of Health-System Pharmacy;2024-07-24

4. Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South;AIDS Research and Human Retroviruses;2024-07-16

5. Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics;Open Forum Infectious Diseases;2024-05-13